LENZ Therapeutics, Inc. (LENZ) Misses Q3 EPS by 59c

LENZ Therapeutics, Inc. (NASDAQ: LENZ) reported Q3 EPS of ($0.59). Revenue for the quarter came in at $12.5 million.

For earnings history and earnings-related data on LENZ Therapeutics, Inc. (LENZ) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• Bank of America to redeem CAD1.425 billion in Canadian senior notes
• CORVEX (MOVE) files $500M mixed shelf